Showing results (91-100 of 224) with videos related to

Sort By:
Pageof 23
Breast Cancer Research and Treatment|October 26, 2006
Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapyKan Yonemori, Noriyuki Katsumata, Masayuki Kaneko, et al.
The Oncologist|July 15, 2009
Factors that affect the duration of the interval between the completion of palliative chemotherapy and deathKenji Hashimoto, Kan Yonemori, Noriyuki Katsumata, et al.
Cancer Science|May 6, 2017
Pathological features of triple-negative breast cancers that showed progressive disease during neoadjuvant chemotherapyYuko Tanabe, Hitoshi Tsuda, Masayuki Yoshida, et al.
Breast Cancer (Tokyo, Japan)|November 21, 2020
Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in JapanMasataka Sawaki, Akimitsu Yamada, Hiraku Kumamaru, et al.
Breast (Edinburgh, Scotland)|April 17, 2013
Use of the neo-adjuvant exemestane in post-menopausal estrogen receptor-positive breast cancer: a randomized phase II trial (PTEX46) to investigate the optimal duration of preoperative endocrine therapyTakashi Hojo, Takayuki Kinoshita, Shigeru Imoto, et al.
Case Reports in Oncology|January 24, 2013
Primary yolk sac tumor of the omentum: a case report and literature reviewKenichi Harano, Masashi Ando, Yuko Sasajima, et al.
Cancer|November 26, 2009
Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancerKan Yonemori, Koji Tsuta, Makiko Ono, et al.
Cancer Science|August 30, 2008
N-Glycan fucosylation of epidermal growth factor receptor modulates receptor activity and sensitivity to epidermal growth factor receptor tyrosine kinase inhibitorKazuko Matsumoto, Hideyuki Yokote, Tokuzo Arao, et al.
Gynecologic Oncology|February 16, 2012
A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancerRyo Kitagawa, Noriyuki Katsumata, Masashi Ando, et al.
Cancer Chemotherapy and Pharmacology|August 20, 2011
Phase I and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancerMasashi Ando, Kan Yonemori, Noriyuki Katsumata, et al.
Pageof 23